Category

Daily Briefs

Daily Brief United States: KLA-Tencor Corp and more

By | Daily Briefs, United States

In today’s briefing:

  • KLAC. Bouncing Along The Bottom


KLAC. Bouncing Along The Bottom

By William Keating

  • Q323 revenues of $2.40 billion, at the upper end of the guidance range, up 2% QoQ but down 12.5% YoY
  • Current quarter revenue forecast of $2.45 billion, essentially flat sequentially
  • Services revenue on track for ~8% YoY growth despite overall revenues tracking to an 8.6% YoY decline..

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Onewo , Cainiao Smart Logistics, Lalatech Holdings Co Ltd, CIMC Enric Holdings, Alibaba Group Holding , Aier Eye Hospital Group, China Vanke (H), Gajah Tunggal and more

By | China, Daily Briefs

In today’s briefing:

  • Onewo (2602 HK) – Full Circulation & HSCI Inclusion
  • Cainiao Smart Logistics IPO: The Bear Case
  • Lalatech (货拉拉) Pre-IPO: To Understand Revenue Growth from Drivers’ Complaints and Strike
  • CIMC Enric (3899 HK): Surge in Overall New Order Momentum
  • China Consumption Weekly (30 Oct 2023): Alibaba, Trip.com, New Oriental, Weibo
  • Aier Eye Hospital (300015.CH) 23Q3 – While Enjoy the Rebound, Recognize the Endgame Behind the Story
  • Quiddity HK Connect SOUTHBOUND (To 27-Oct-23); Meituan & Tech IN, High Div SOEs OUT, Financials MIA
  • Morning Views Asia: China Vanke , Gajah Tunggal, Reliance Industries, Xiaomi Corp


Onewo (2602 HK) – Full Circulation & HSCI Inclusion

By Brian Freitas

  • Onewo (2602 HK) has announced the full conversion of 1.05bn Domestic Shares and Unlisted Foreign Shares to H-shares. The increased market cap will help in HSCI inclusion.
  • Onewo (2602 HK) should be added to the HSCI in March and will be added to Southbound Stock Connect soon after index inclusion.
  • Onewo (2602 HK) has drastically underperformed its peers since listing and the HSCI inclusion could mark a turning point for the stock.

Cainiao Smart Logistics IPO: The Bear Case

By Arun George

  • Cainiao Smart Logistics (1437124D HK), a global leader in e-commerce logistics, has filed for a HKEx IPO to raise at least US$1 billion at a US$15-20 billion valuation.
  • In Cainiao Smart Logistics IPO: The Bull Case, we highlighted the key elements of the bull case. In this note, we outline the bear case.
  • The bear case rests on declining global cross-border market share, China logistics decelerating growth, high related-party transactions, and FCF burn. 

Lalatech (货拉拉) Pre-IPO: To Understand Revenue Growth from Drivers’ Complaints and Strike

By Ming Lu

  • Lalatech charges drivers more commissions but less membership fees to raise the general fees.
  • Drivers went on strike to protest against the income squeeze, but they did not  achieve their target.
  • We believe Lalatech is the dominator of the low-end truck-hiring market.

CIMC Enric (3899 HK): Surge in Overall New Order Momentum

By Osbert Tang, CFA

  • CIMC Enric Holdings (3899 HK) has a solid 3Q23 with excellent new order pick-up, surging by 52.8% YoY on the back of strengths in clean energy and liquid food segments.
  • Hydrogen energy revenue is on target to reach Rmb700m in FY23. Meanwhile, management revealed that there is a slight gross margin expansion so far this year.
  • With order backlog rising 27.6% YoY to Rmb22.2bn at end-9M23, earnings outlook is well protected. Its net cash position is another credit, making its premium multiples justified.

China Consumption Weekly (30 Oct 2023): Alibaba, Trip.com, New Oriental, Weibo

By Ming Lu

  • JD is in fact competing with a broadcaster on Alibaba’s app, but not Alibaba itself.
  • Trip.com’s domestic orders during National Holidays were double last year.
  • New Oriental’s revenue increased strongly with new learning centers in 1Q24.

Aier Eye Hospital (300015.CH) 23Q3 – While Enjoy the Rebound, Recognize the Endgame Behind the Story

By Xinyao (Criss) Wang

  • Aier’s 23Q3 profit growth exceeded expectations. Considering the low base in 22Q4, Aier’s 23Q4 performance could show an obvious rebound. Then, the 2023 full-year results would be more certain.
  • Aier has a considerable amount of “off-balance-sheet profits” that can be incorporated into statements in the future. So, although Aier’s growth rate has decreased, it wouldn’t collapse in short term.
  • More hidden problems would be exposed in the process of transferring off-balance sheet profits to the on-balance sheet. All the repurchased shares should be cancelled to reduce Aier’s registered capital.

Quiddity HK Connect SOUTHBOUND (To 27-Oct-23); Meituan & Tech IN, High Div SOEs OUT, Financials MIA

By Travis Lundy

  • This is the somewhat brand-spanking-new Quiddity HK Connect SOUTHBOUND Monitor. We work off the same presentation as the A/H Premium Monitor and Mainland Connect NORTHBOUND Monitor.
  • Last week, China Mobile (941), SMIC (981) and CNOOC (883) all saw total SOUTHBOUND turnover top 75% of value traded on a gross basis, indicating huge participation. 
  • Meituan was again the top SOUTHBOUND inflow, now net inflow every day for more than a month. Total Net Inflows at HK$6.9bn now 14 weeks straight in the positive column.

Morning Views Asia: China Vanke , Gajah Tunggal, Reliance Industries, Xiaomi Corp

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: Kenedix Office Investment Co, Nikkei 225, JSR Corp, M3 Inc and more

By | Daily Briefs, Japan

In today’s briefing:

  • KDX (8972) – The Kenedix REIT Merger After a Disastrous Index Inclusion Trade
  • EQD | If the Nikkei Begings to Rally, Where Will It Encounter Resistance?
  • Merger Arb Mondays (30 Oct) – JSR, Eoflow, Azure Minerals, Symbio, Hollysys, Haitong Intl
  • M3: Margins Continue to Dip and Likely to Miss Full Year Guidance


KDX (8972) – The Kenedix REIT Merger After a Disastrous Index Inclusion Trade

By Travis Lundy


EQD | If the Nikkei Begings to Rally, Where Will It Encounter Resistance?

By Nico Rosti

  • Last week, the Nikkei closed down at 30991.69 (CC=-2). The index’s sell-off could end in November, marking a temporary bottom from which a rally could start.
  • MRM models say that if the Nikkei bounces this week, it could rise for 3 weeks and reach a price area between 31624 (Q3/CC=+1) and 32892 (Q3/Gen.Pattern Boxplot).
  • The upcoming rally comes as a reaction to quite OVERSOLD conditions, as previously discussed, but could be followed by another pullback. This insight points to where the rally may end.

Merger Arb Mondays (30 Oct) – JSR, Eoflow, Azure Minerals, Symbio, Hollysys, Haitong Intl

By Arun George


M3: Margins Continue to Dip and Likely to Miss Full Year Guidance

By Shifara Samsudeen, ACMA, CGMA

  • M3 Inc (2413 JP) reported 2QFY03/2023 results on Friday. Revenues increased 3.0YoY while OP decreased 7.1% YoY, both revenues and OP fell below consensus estimates by 0.2% and 4.7% respectively.
  • Medical Platform’s earnings continue to deteriorate while we are yet to see a meaningful improvement in overseas segment’s earnings to drive the next phase of growth for m3.
  • Given continued decrease in profits, we think the company will struggle to meet its full-year guidance suggesting there is further downside to m3’s share price.  

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Quantitative Analysis: TWSE Short Interest Weekly (Oct 27th): Nan Ya Printed and more

By | Daily Briefs, Quantitative Analysis

In today’s briefing:

  • TWSE Short Interest Weekly (Oct 27th): Nan Ya Printed, Asmedia Tech, Global Unichip, TSMC


TWSE Short Interest Weekly (Oct 27th): Nan Ya Printed, Asmedia Tech, Global Unichip, TSMC

By Ke Yan, CFA, FRM

  • We analyzed the changes in short interest of TWSE Stocks as of Oct 27th which has an aggregated short interest worth USD13.7bn.
  • We tabulate league table for top short by value and short as multiple of ADT, as well as weekly increases & decreases in short value, short as multiple of ADT.
  • We highlight short interest changes in Nan Ya Printed, Asmedia Tech, Global Unichip, TSMC.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ESG: % of Female Board Members Asks “Seriousness” Of Improving Profitability and Governance Etc. and more

By | Daily Briefs, ESG

In today’s briefing:

  • % of Female Board Members Asks “Seriousness” Of Improving Profitability and Governance Etc.
  • Only 20% of Current CEOs in Japan Expected to Have a Female CEO Within 10 Years


% of Female Board Members Asks “Seriousness” Of Improving Profitability and Governance Etc.

By Aki Matsumoto

  • While necessary talent should be sought from both outside and inside the company, it is not good for the company’s future if the most of internal executive directors are male.
  • The appointment of women and foreign board members is an effective way to transform the board of directors to ensure transparency and objectivity, without compromising the traditional atmosphere of familiarity.
  • Companies with a higher percentage of female board members tend to be more proactive in their corporate governance practices and more diligent about improving profitability and stock valuation.

Only 20% of Current CEOs in Japan Expected to Have a Female CEO Within 10 Years

By Aki Matsumoto

  • The group of companies with lower than 25% female board member will only manage to meet the targets by “matching numbers,” as few companies have high awareness regarding the practice.
  • Since the government target of 30% female managers was set in 2005, companies’ awareness remains low. It’s not easy to raise the ratio to 30% by the methods so far.
  • There are a number of initiatives that will not progress unless top management is replaced by women, including accelerated promotion of women to management positions and female board members.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Energy/Materials: Newcrest Mining and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • Last Week In Event SPACE: Newcrest/Newmont, Keisei Electric, PCCW, Cosmo Energy, Leapmotor


Last Week In Event SPACE: Newcrest/Newmont, Keisei Electric, PCCW, Cosmo Energy, Leapmotor

By David Blennerhassett


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief TMT/Internet: GMO Payment Gateway, Kokusai Electric and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • Index Rebalance & ETF Flow Recap: KS200, KQ150, Yuanta Div+, LIT, HSCI, IDX, Japan Positioning
  • ECM Weekly (29th Oct 2023) – Kokusai, J&T, Midea, Wuxi XDC, Cirrus, Cello World, Honasa, SIA


Index Rebalance & ETF Flow Recap: KS200, KQ150, Yuanta Div+, LIT, HSCI, IDX, Japan Positioning

By Brian Freitas


ECM Weekly (29th Oct 2023) – Kokusai, J&T, Midea, Wuxi XDC, Cirrus, Cello World, Honasa, SIA

By Sumeet Singh

  • Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
  • In the IPO space, Kokusai Electric (6525 JP) provided some relief in the ECM space, even as J&T Global Express (1519 HK) didn’t do much.
  • Given the earnings seasons, there weren’t any placement during the week. We did look at Singapore Airlines (SIA SP)‘s upcoming placement lockup expiry. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: ECM Weekly (29th Oct 2023) – Kokusai and more

By | Daily Briefs, ECM

In today’s briefing:

  • ECM Weekly (29th Oct 2023) – Kokusai, J&T, Midea, Wuxi XDC, Cirrus, Cello World, Honasa, SIA


ECM Weekly (29th Oct 2023) – Kokusai, J&T, Midea, Wuxi XDC, Cirrus, Cello World, Honasa, SIA

By Sumeet Singh

  • Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
  • In the IPO space, Kokusai Electric (6525 JP) provided some relief in the ECM space, even as J&T Global Express (1519 HK) didn’t do much.
  • Given the earnings seasons, there weren’t any placement during the week. We did look at Singapore Airlines (SIA SP)‘s upcoming placement lockup expiry. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): GEMWeekly (27 Oct 2023): South Korea and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • GEMWeekly (27 Oct 2023): South Korea, China Macro; Hon Hai, Foxconn, Naver, SMIC


GEMWeekly (27 Oct 2023): South Korea, China Macro; Hon Hai, Foxconn, Naver, SMIC

By Wium Malan, CFA


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Siloam International Hospitals, Eoflow , Livzon Pharmaceutical Group, Lansen Pharmaceutical Holdings Co, Ltd., SK Bioscience , TSE Tokyo Price Index TOPIX and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Siloam International Hospitals (SILO IJ) – Sustainable Base Case Revival
  • (Mostly) Asia-Pac Weekly Risk Arb Wrap: Azure, EOFlow, Hollysys, Essential Metals, Celltrion Health
  • China Healthcare Weekly (Oct.27) – TCM Formula Granules VBP, Medical Statistics to Watch, Livzon
  • Lansen Pharma (503 HK): 27th November Scheme Vote
  • SK Bioscience (302440 KS): Significantly Improved 3Q Result Benefitted From One-Time Payment
  • % of Female Board Members Asks “Seriousness” Of Improving Profitability and Governance Etc.
  • Only 20% of Current CEOs in Japan Expected to Have a Female CEO Within 10 Years


Siloam International Hospitals (SILO IJ) – Sustainable Base Case Revival

By Angus Mackintosh

  • Siloam International Hospitals booked strong set of 3Q2023 with continuing evidence of the recovery in its core base-case business together with the effectiveness of its cost and efficiency initiatives. 
  • The company saw a strong recovery across outpatient visits and inpatient admissions, with evidence of greater treatment complexity along with higher intensity with less time spent in hospital. 
  • Siloam International Hospitals continues to focus on digitising its processes to improve both patient experience and its internal processes. Valuations remain attractive versus listed peers.

(Mostly) Asia-Pac Weekly Risk Arb Wrap: Azure, EOFlow, Hollysys, Essential Metals, Celltrion Health

By David Blennerhassett


China Healthcare Weekly (Oct.27) – TCM Formula Granules VBP, Medical Statistics to Watch, Livzon

By Xinyao (Criss) Wang

  • The results of the first VBP of TCM formula granules in China were announced. 200 varieties of TCM formula granules have been included, with an average price reduction of 50.77%.
  • According to the recently released Statistical Bulletin on the Development of Health Care in 2022, we have listed some key points worth investors’ attention.
  • Livzon’s 23Q3 performance was below expectations, which was more related to external factors such as anti-corruption campaign, VBP. However, Chairman’s share buyback proposal indicates possibility of a future reversal.

Lansen Pharma (503 HK): 27th November Scheme Vote

By David Blennerhassett

  • On the 17 September, specialty prescription drug manufacturer Lansen Pharmaceutical Holdings Co, Ltd. (503 HK), a perennial takeover target, finally announced an Offer.
  • Wu Zhen Tao, NED and Chairman of Lansen, made an Offer for shares not indirectly held, of HK$1.80/share, by way of a Scheme, a 26.76% premium to last close.
  • Composite Doc is now out. Court Meeting is the 27th November. Expected last day of trading is the 28 Nov. 28 December payment. IFA says fair and reasonable. Looks done.

SK Bioscience (302440 KS): Significantly Improved 3Q Result Benefitted From One-Time Payment

By Tina Banerjee

  • In 3Q23, revenue jumped 2.5x YoY and 12.1x QoQ to KRW231.8 billion, mainly due to the inflow related to Novavax vaccine contract settlement and resumption of flu vaccine production.
  • Despite significantly improved Q3 result, SK Bioscience is expected to end 2023 on a weak note, due to the absence of contract manufacturing revenue from Novavax.
  • SK Bioscience has applied for EUA for the updated Novavax COVID-19 vaccine in Korea. Once approved, the company targets to distribute the vaccine during 2023–2024 winter seasons in Korea.

% of Female Board Members Asks “Seriousness” Of Improving Profitability and Governance Etc.

By Aki Matsumoto

  • While necessary talent should be sought from both outside and inside the company, it is not good for the company’s future if the most of internal executive directors are male.
  • The appointment of women and foreign board members is an effective way to transform the board of directors to ensure transparency and objectivity, without compromising the traditional atmosphere of familiarity.
  • Companies with a higher percentage of female board members tend to be more proactive in their corporate governance practices and more diligent about improving profitability and stock valuation.

Only 20% of Current CEOs in Japan Expected to Have a Female CEO Within 10 Years

By Aki Matsumoto

  • The group of companies with lower than 25% female board member will only manage to meet the targets by “matching numbers,” as few companies have high awareness regarding the practice.
  • Since the government target of 30% female managers was set in 2005, companies’ awareness remains low. It’s not easy to raise the ratio to 30% by the methods so far.
  • There are a number of initiatives that will not progress unless top management is replaced by women, including accelerated promotion of women to management positions and female board members.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars